Research Article

Circulating Fractalkine Levels Predict the Development of the Metabolic Syndrome

Table 3

Association of baseline fractalkine concentrations with metabolic parameters at year 2 ( ).

VariablesQ1Q2Q3Q4 for trend
≤0.28 ng/mL0.28–0.43 ng/mL0.43–0.64 ng/mL 0.64 ng/mL

(case/control)115114115115
Fractalkine (ng/mL)0.18 (0.10–0.23)0.35 (0.30–0.40)0.51 (0.48–0.57)0.71 (0.66–0.78)<0.001
Age (years) <0.001
Male, (%)39 (35.4)42 (37.8)44 (38.9)45 (39.8)0.855
Education0.992
 Less than high school11 (9.7)11 (9.9)11 (9.7)13 (11.5)
 High school86 (76.1)83 (74.8)88 (77.9)83 (73.5)
 More than high school16 (14.2)17 (15.3)14 (12.4)17 (15.0)
Current smoker, (%)24 (21.2)24 (21.6)22 (19.5)29 (25.7)0.717
Alcohol drinker, (%)15 (13.3)24 (21.6)25 (22.1)29 (25.7)0.127
MetS, (%)6 (6.6)14 (12.6)31 (27.4)40 (35.4)<0.001
BMI (kg/m2) 0.001
WC (cm) <0.001
WHR <0.001
Fat% (%) 0.006
SBP (mm Hg) 0.117
DBP (mm Hg) 0.069
FPG (mmol/L)5.00 (4.70–5.20)5.10 (4.90–5.45)5.10 (4.80–5.50)5.30 (5.00–5.85)<0.001
2 h PG (mmol/L)5.50 (4.30–6.50)5.60 (4.65–6.60)5.80 (5.00–7.00)5.90 (5.10–7.95)<0.001
FINS ( U/mL)5.83 (4.20–9.28)7.89 (5.90–9.91)8.44 (5.86–11.25)8.30 (5.94–11.48)<0.001
2 h INS ( U/mL)27.62 (16.32–47.32)33.52 (20.67–49.04)39.60 (22.25–61.16)36.55 (23.53–65.52)0.002
HOMA-IR1.27 (0.85–2.08)1.78 (1.36–2.30)1.93 (1.31–2.68)2.08 (1.39–2.73)<0.001
HbA1c (%) 0.060
TC (mmol/L)4.80 (4.20–5.60)5.05 (4.20–5.80)5.00 (4.70–5.60)5.30 (4.70–5.80)0.013
LDL-c (mmol/L) 0.137
HDL-c (mmol/L) 0.035
TG (mmol/L)1.00 (0.80–1.40)1.15 (0.90–1.73)1.40 (1.00–1.85)1.60 (1.10–2.10)<0.001

Variables with normal distributions are presented as mean ± SD; skewed variables are presented as the median value (interquartile range) [M (IQR)].
The chi-squared test was used for categorical values and ANOVA test for continuous values.
Abbreviations as in Table 1.